5Kim D K,Yoo T H,Ryu D R,et al.Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis:a single center's experience over one decade[J].Petit Dial Int,2004,24(5):424-32.
6Coffin E,Pouthier D,Pochet J M,et al.Vaneomycin and ciprofloxacin:systemic adtibiotic administration for peritoneal dialysis-associated peritonitis[J].Petit Dial Int,2004,24 (5):416-8.
7Baker R J,Senior H,Clemenger M,et al.Empirical aminoglyeosides for peritonitis do not affect residual renal function[J].Am J Kidney Dis,2003,41 (3):670 -5.
8Figueiredo AE,Poli de Figueiredo CE,D′Avila DO.Bag exchange in continuous ambulatory peritoneal dialysis without use of a face mask:experience of five year.Adv Perit Dial,2001,17:98-100.
9Li PK,Law MC,Chow KM,et al.Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis:a prospective,randomized,controlled multicenter study.Am J Kidney Dis,2002,40(2):373-380.
10Kim DK,Yoo TH,Ryu DR,et al.Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis:a single center's experience over one decade.Perit Dial Int,2004,24(5):424-432.
2DAVENPORT A.Peritonitis remains the major clinical complication of peritoneal dialysis:the London,UK,peritonitis audit 2002-2003[J].Petit Dial Int,2009,29:297-302.
3PIRAINO B.Insignt on peritoneal dialysis-related infection[J].Contrib Nephrol Epub,2009,3:161-168.
4GOVINDARAJULU S,HAWLEY CM,MCDONALD SP,et al.Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients:predictors,treatment,and outcomes in 503 cases[J].Perit Dial Int,2010,30(3):311-319.
5FURGESON S B,TEITELBAUM I.New treatment options and protocols for peritoneal dialysis-related peritonitis[J].Contrib Nephrol,2009,163:169-176.
6MILES R,HAWLEY CM,MCDONALD SP,et al.Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients[J].Kidney Int,2009,76:622-628.
